Relationship of β3-adrenergic receptor polymorphism with metabolic syndrome and oxidative stress parameters in postmenopausal women;Zwiazek polimorfizmu receptora β3-adrenergicznego z wystepowaniem parametrów zespolu metabolicznego i stresu oksydacyjnego u kobiet po menopauzie

Endokrynologia Polska

Volumn 58, Issue 3, 2007, Pages 201-206

  Dunajska, Katarzyna ^a   Lwow, Felicja ^a   Tworowska, Urszula ^b   Jedrzejuk, Diana ^b   Milewicz, Andrzej ^b  

^a UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

3 Adrenergic receptor; Metabolic syndrome; Oxidative stress; Polymorphism; Postmenopausal women

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; EXERCISE TEST; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE;

EXERCISE TEST; FEMALE; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, ADRENERGIC, BETA-3; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 38449122382     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gleim GW, Glace BW. Energy balance and weight control (male and female). W: Warren PM, Constantini NW. Sports Endocrinology, Human Press Inc, Totowa, NJ, 2000; 189-205.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1567.
3. Hubert HB, Fenileb M, McNamara PM i wsp. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 1983; 67: 968-977.
4. Larsson B, Svardsudd K, Welin L i wsp. Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13-year follow-up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401-1404.
5. Large V, Hellstrom L, Reynisdottir S i wsp. Human beta2 adrenoreceptor gene polymorphisms are highly frequent in obesity and associate with alterate adipocyte beta2 adrenoreceptor function. J Clin Invest 1997; 100: 3005-3013.
6. Dallongeville J, Helbecque N, Cottel D i wsp. The Gly16-Arg16 and Gln27-Glu27 Polymorphism of B2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab 2003; 88: 4862-4866.
7. Meirenhaeghe A, Luan J, Selberg-Franks P i wsp. The effect of the Gly16Arg polymorphism of the beta2 adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity. J Clin Endocrinol Metab 2001; 86: 5881-5887.
8. Hoffstedt J, Shimizu M, Sjostedt S i wsp. Determination of beta3-adrenoreceptor mediated lipolysis in human fat cells. Obes Res 1995; 3: 447-457.
9. Revelli JP, Preitner F, Samec S i wsp. Targeted gene disruption reveals a leptin independent role for the mouse beta3 adrenoreceptor in the regulation of body composition. J Clin Invest 1997; 100: 1098-1106.
10. Clement K, Ruiz J, Cassard-Doulcier AM i wsp. Additive effect of A-G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta3 adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord 1996; 20: 1062-1066.
11. Clement K, Vaisse C, Manning BS i wsp. Genetic variation in the beta3 adrenergic receptor and an increased capacity to gain wieght in patients with morbid obesity. N Engl J Med 1995; 333: 322-354.
12. Walston J, Silver K, Bogardus C i wsp. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta3 adrenergic receptor gene. N Engl J Med 1995; 333: 343-347.
13. Widen E, Lehto M, Kanninen T i wsp. Association of a polymorphism in the beta3 adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-351.
14. Shima Y, Tsukada T, Nakanishi K i wsp. Association of the Trp64Arg mutation of the beta3-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects. Clin Chim Acta 1998; 274: 167-176.
15. Fujisawa T, Ikegami H, Kawaguchi Y i wsp. Meta-analysis of the association of Trp64Arg polymorphism of beta3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 1998; 83: 2441-2444.
16. Mitchell BD, Blangero J, Comuzzie AG i wsp. A paired sibling analysis of the beta3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest 1998; 101: 584-587.
17. Mitchell BD, Cole SA, Comuzzie AG. A quantitative trait locus influencing BMI maps to the region of the beta3-adrenergic receptor. Diabetes 1999; 48: 1863-1867.
18. Gagnon J, Mauriege P, Roy S i wsp. The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 1996; 98: 2086-2093.
19. Garcia Rubi E, Calles-Escandon J. Insulin resistance and type 2 Diabetes Mellitus: its relationship with the beta3 adrenergic receptor. Endocrinol Diab 1999; 30: 459-464.
20. Urakawa H, Katsuki A, Sumida Y i wsp. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003; 88: 4673-4676.
21. Dandona P, Mohanty P, Ghanim H i wsp. The supressive effect of dietetary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocotes, lipid peroxidation and protein carbonylation. J Clin Endocrinol 2003; 86: 355-362.
22. Williams IL, Wheatcroft SB, Shah AM i wsp. Obesity, atherosclerosis and the vascular endothelium: mechanism of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord 2002; 26: 754-764.
23. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids 1987; 366: 1-15.
24. Jentzsch AM, Bachmann H, Fürst P i wsp. Improved analysis malondialdehyde in human body fluids. Free Radic Biol Med 1996; 20: 251-256.
25. Lapenna D, Ciofani G, Pierdomenico SD i wsp. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 2001; 31: 331-335.
26. Thamer C, Machann J, Bachmann O i wsp. Intramyocellular lipids: antropometric determinants and relationships with maximal aerobic capacity and insulin sensityvity. J Clin Endocrinol Metab. 2003; 88: 1785-1791.
27. Wasserman K, Hansen JE, Sue DY i wsp. Principles of exercise testing and interpretation. Lea & Febiger, Philadelphia 1987; 73.
28. Matsushita H, Kurabayashi T, Tomita M i wsp. Effects of uncoupling protein 1 and beta3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women. Maturitas 2003; 45: 39-45.
29. Endo K, Yanagi H, Hirano C i wsp. Association of Trp64Arg polymorphism of the beta3-adrenergic receptor gene and no asscociation of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity. Int J Obes Relat Metab Disord 2000; 24: 443-449.
30. Arashiro R, Katsuren K, Fukuyama S i wsp. Effect of Trp64Arg mutation of the beta3-adrenergic receptor gene and C161T substitution of the peroxisome proliferator activated receptor gamma gene polymorphism of the leptin receptor gene in Japanese children. Padiatr Int 2003; 45: 135-141.
31. Shiwaku K, Nogi A, Anuurad E i wsp. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Int J Obes Relat Metab Disord 2003; 27: 1028-1036.
32. Okumura K, Matsui H, Ogawa Y i wsp. The polymorphism of the beta3-adrenergic receptor gene is associated with reduced lowdensity lipoprotein particle size. Metabolism 2003; 52: 356-361.